
elvitegravir-cobicistat-emtricitabin-tenofovir disoprox oral brand names and other generic formulations include:
amoxicillin-clarithromycin-lansoprazole oral brand names and other generic formulations include:
elvitegravir-cobicistat-emtricitabin-tenofovir disoprox oral and amoxicillin-clarithromycin-lansoprazole oral
elvitegravir-cobicistat-emtricitabin-tenofovir disoprox oral , amoxicillin-clarithromycin-lansoprazole oral altering drug metabolism. Based on drug interaction studies conducted with the components of Stribild, no clinically significant drug interactions have been either observed or are expected when taken in this combination.
elvitegravir-cobicistat-emtricitabin-tenofovir disoprox oral and amoxicillin-clarithromycin-lansoprazole oral
elvitegravir-cobicistat-emtricitabin-tenofovir disoprox oral , amoxicillin-clarithromycin-lansoprazole oral affecting hepatic/intestinal enzyme CYP3A4 metabolism. Based on drug interaction studies conducted with the components of Stribild, no clinically significant drug interactions have been either observed or are expected when coadministered with PPIs
Check for more interactions with the Drug Interaction Checker
Drug Interaction Categories
Contraindicated
Never use this combination of drugs because of high risk for dangerous interaction
Serious
Potential for serious interaction; regular monitoring by your doctor required or alternate medication may be needed
Significant
Potential for significant interaction (monitoring by your doctor is likely required)
Minor
Interaction is unlikely, minor, or nonsignificant